Skip to main content
CBAN
NYSE Finance

Colony Bankcorp Posts $0.50 Q3 EPS, Declares $0.12 Dividend and Closes $16.2M Branch Sale-Leaseback

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Bank Stocks · Financial
Sentiment info
Positive
Importance info
7
Price
$18.11
Mkt Cap
$432.059M
52W Low
$15.8
52W High
$22.458
52W Position info
15% above low
Off High info
19% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

CBAN is trading near its 52-week low of $15.8 (15% above the low).

Summary

Colony Bankcorp earned $0.50 per diluted share in Q3 2026, declared a $0.12 quarterly dividend, and closed a $16.2 million branch sale-leaseback that should produce a roughly $15 million pre-tax gain to fund a securities portfolio repositioning.


Key Events · Earnings and Guidance · CBAN

  • Q3 Earnings and Dividend Declared

    Net income was $10.5 million, or $0.50 per diluted share, versus $5.8 million, or $0.33, a year earlier; operating EPS was $0.54. The board declared a $0.12 quarterly dividend payable November 25, 2026 to holders of record November 11, 2026.

  • Branch Sale-Leaseback Closed

    Colony Bank sold the Manchester and Thomaston, Georgia branches for $16,188,253 on October 27, 2026 and signed a 15-year triple-net master lease at $1,343,625 of initial annual rent. A third property in Tifton ($3,714,157) remains subject to buyer inspection and closing conditions and would lift rent to $1,651,900.

  • Securities Repositioning Planned

    The roughly $15 million expected pre-tax gain on the sale-leaseback is intended to offset realized losses from selling about $100 million of available-for-sale securities yielding approximately 2.00%, with proceeds reinvested at an assumed weighted-average 5.5%.

  • Credit Metrics Deteriorated

    Nonperforming assets rose to $25.0 million from $20.9 million at June 30, 2026, and classified loans increased to $53.9 million from $33.6 million, primarily from the downgrade of one construction relationship. The allowance for credit losses was 0.91% of total loans.


Analysis · CBAN · Finance

Three things landed at once: third-quarter earnings, the dividend, and a balance-sheet repositioning. Net income of $10.5 million ($0.50 per diluted share) was down slightly from $10.9 million in the second quarter but nearly double the $5.8 million earned a year ago, and net interest margin rose for an eighth straight quarter to 3.59%. The more consequential item is the sale-leaseback: Colony sold two branches for $16.2 million, will sell a third for $3.7 million, and leased them all back for 15 years at $1.34 million of annual rent stepping up to $1.65 million. Management expects a roughly $15 million pre-tax gain, which it plans to spend offsetting losses on selling about $100 million of low-yielding (roughly 2.00%) securities and reinvesting near 5.5%. That trade swaps paper losses for a better-earning balance sheet and is described as accretive to tangible book value and recurring earnings, though it adds $1.8 million of annual rent expense. Credit is the offsetting concern: nonperforming assets rose to $25.0 million from $20.9 million and classified loans jumped to $53.9 million from $33.6 million, driven largely by one construction relationship.

How filings like this one have moved

In the 30 days to Oct 29, 2026, 31.1% of the 1661 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CBAN was trading at $18.11 on NYSE in the Finance sector, with a market capitalization of approximately $432.1M. The 52-week trading range was $15.80 to $22.46. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CBAN - Latest Insights

CBAN
Oct 15, 2026, 4:15 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $20.03
Real-time Price: $18.11 info
Change: -$1.92 (-10%) info
Market Cap: $432.059M info
CBAN
Sep 17, 2026, 8:30 AM EDT
Source: BusinessWire
Importance Score:
9
Price at Filing: $21.06
Real-time Price: $18.11 info
Change: -$2.95 (-14%) info
Market Cap: $432.059M info
CBAN
Aug 27, 2026, 5:00 PM EDT
Filing Type: 424B4
Importance Score:
7
Price at Filing: $21.29
Real-time Price: $18.11 info
Change: -$3.18 (-15%) info
Market Cap: $432.059M info
CBAN
Aug 14, 2026, 5:24 PM EDT
Filing Type: S-4
Importance Score:
8
Price at Filing: $22.27
Real-time Price: $18.11 info
Change: -$4.16 (-19%) info
Market Cap: $432.059M info
CBAN
Jul 22, 2026, 4:35 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $20.74
Real-time Price: $18.11 info
Change: -$2.63 (-13%) info
Market Cap: $432.059M info